Breast (Apr 2021)

Residual disease after a neoadjuvant therapy: a strong prognostic and potentially predictive biomarker to personalize therapy

  • I. Krop

Journal volume & issue
Vol. 56
pp. S13 – S14

Abstract

Read online

No abstracts available.